Work

Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.

Year: 2000

Type: article

Source: PubMed

Authors: A Cheng-Lai, A Levine

Institutions: Montefiore Medical Center, Yeshiva University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2404173151

FWCI: 0.842

Cites:

Cited by: 36

Related to: 10